Interestingly, our data showed that activation markers, such as CD38&HLA-DR, were highly expressed in CD11c+CD8+ T cells in tumor tissues, as well as PD-1, compared to that of CD11c+CD8+ T cells in peripheral blood. This evidence concerns the gene CD8A and neoplasm.